Crinetics Pharmaceuticals (CRNX) EPS (Basic) Growth (1y) (2018 - 2026)
Crinetics Pharmaceuticals (CRNX) EPS (Basic) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | - |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 17,151.81% |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 88.81% |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 1,201.33% |
| 10 | Crinetics Pharmaceuticals | 8.74 Bn | 7.45 Bn | 10.53 Mn | -330.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -330.37% |
| Dec 31, 2025 | -30.69% |
| Sep 30, 2025 | -43.94% |
| Jun 30, 2025 | 31.54% |
| Mar 31, 2025 | 13.06% |
| Dec 31, 2024 | 84.03% |
| Sep 30, 2024 | -196.52% |
| Jun 30, 2024 | -0.21% |
| Mar 31, 2024 | 7.75% |
| Dec 31, 2023 | -821.76% |
| Sep 30, 2023 | 27.46% |
| Jun 30, 2023 | 16.42% |
| Mar 31, 2023 | 21.09% |
| Dec 31, 2022 | 118.03% |
| Sep 30, 2022 | 7.25% |
| Jun 30, 2022 | 14.59% |
| Mar 31, 2022 | 1.57% |
| Dec 31, 2021 | -563.16% |
| Sep 30, 2021 | 163.15% |
| Jun 30, 2021 | 154.10% |